Toni Weinschenk

4PUBLICATIONS
74CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyNanomedicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 12, 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.

Apostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson

|Aug 31, 2022
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.

Gloria B Kim, Jens Fritsche, Sebastian Bunk

|Apr 14, 2022
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.

Markus W Löffler, Stefania Gori, Francesco Izzo

|Sep 27, 2018
RNA editing derived epitopes function as cancer antigens to elicit immune responses.

Minying Zhang, Jens Fritsche, Jason Roszik

Pageof 1

Frequent Collaborators

3 joint publications

Jens Fritsche

2 joint publications

Dominik Maurer

2 joint publications

Claudia Wagner

2 joint publications

Amir Alpert